Key Events This Week
20 Apr: New 52-week high (Rs.927.1) and all-time high (Rs.923.1)
21 Apr: Price correction amid broader market gains
22 Apr: Continued decline with moderate volume
23 Apr: Recovery rally despite Sensex decline
24 Apr: Week closes lower at Rs.890.40 (-1.14%)

Senores Pharmaceuticals Ltd is Rated Buy
2026-04-20 10:10:03Senores Pharmaceuticals Ltd is rated Buy by MarketsMOJO, with this rating last updated on 08 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 927.1
2026-04-20 09:49:02With a sustained rally that has propelled Senores Pharmaceuticals Ltd to a new 52-week and all-time high of Rs 927.1 on 20 Apr 2026, the stock’s momentum is unmistakable. This surge follows eight consecutive days of gains, delivering a remarkable 20.22% return in that span and outpacing its sector by 3.53% today alone.
Read full news articleCorporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available











